Nutritional Status Impairment Due to Neoadjuvant Chemotherapy Predicts Post-Radical Cystectomy Complications. Academic Article uri icon

Overview

abstract

  • BACKGROUND: Radical cystectomy (RC) is the standard treatment for muscle invasive bladder cancer (MIBC). Neoadjuvant chemotherapy (NAC) is associated with improved patient survival. The impact of NAC on nutritional status is understudied, while the association between malnutrition and poor surgical outcomes is well known. This study aims to examine the association between NAC, nutritional status impairment, and post-operative morbidity. MATERIALS AND METHODS: We included MIBC patients who underwent RC and received NAC from multiple academic centers in Israel. Cross-sectional imaging was used to measure the psoas muscle area and normalized it by height (smooth muscle index, SMI). Pre- and post-NAC SMI difference was calculated (represents nutritional status change). The primary outcomes were post-RC ileus, infection, and a composite outcome of any complication. Logistic regression models were fit to identify independent predictors of the outcomes. RESULTS: Ninety-one patients were included in the study. The median SMI change was -0.71 (-1.58, -0.06) cm2/m2. SMI decline was significantly higher in patients with post-RC complications (-18 vs. -203, p < 0.001). SMI change was an independent predictor of all complications, ileus, infection, and other complications. The accuracy of SMI change for predicting all complications, ileus, infection, and other complications was 0.85, 0.87, 0.75, and 0.86, respectively. CONCLUSIONS: NAC-related nutritional deterioration is associated with increased risk of complications after RC. Our results hint towards the need for nutritional intervention during NAC prior to RC.

authors

  • Cohen, Sharon
  • Gal, Jonathan
  • Freifeld, Yuval
  • Khoury, Sobhi
  • Dekel, Yoram
  • Hofman, Azik
  • Malshi, Kamil
  • Amiel, Gilad
  • Sagi, Itay
  • Leibovici, Ilan
  • Golan, Shay
  • Baniel, Jack
  • Rozenzweig, Barak
  • Dotan, Zohar
  • Haifler, Miki

publication date

  • December 14, 2021

Research

keywords

  • Antineoplastic Agents
  • Cystectomy
  • Neoadjuvant Therapy
  • Nutritional Status
  • Urinary Bladder Neoplasms

Identity

PubMed Central ID

  • PMC8708207

Scopus Document Identifier

  • 85121056453

Digital Object Identifier (DOI)

  • 10.3390/nu13124471

PubMed ID

  • 34960023

Additional Document Info

volume

  • 13

issue

  • 12